Logout succeed
Logout succeed. See you again!
2014 Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Midd PDF
13 Pages
2014
5.6 MB
EnglishPreview 2014 Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Midd
Evaluation of SSYA10-001 as a Replication Inhibitor of SARS, MHV and MERS 1 Coronaviruses 2 3 Adeyemi O. Adedeji1,2,#, Kamalendra Singh1,2, Ademola Kassim 1,2 , Christopher M. 4 Coleman3, Ruth Elliott 4, Susan R. Weiss4, Matthew B. Frieman3 and Stefan G. 5 Sarafianos1,2,5,* 6 7 1Christopher Bond Life Sciences Center, University of Missouri, Columbia, MO 65211; 8 2Department of Molecular Microbiology & Immunology, University of Missouri School 9 of Medicine, Columbia, MO 65211; 3Department of Microbiology & Immunology, 10 University of Maryland School of Medicine, Baltimore, MD 21201; 4Department of 11 Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; 12 5Department of Biochemistry, University of Missouri, Columbia, MO 65211. 13 14 15 Running head: Specific inhibitor of SARS, MHV and MERS coronaviruses 16 17 * To whom correspondence should be addressed. Tel: +1-573-882-4338; 18 Fax: +1-573-884-9676; Email:
